α-Pyrrolidinopentiophenone
| Clinical data | |
|---|---|
| Other names | α-Pyrrolidinovalerophenone; α-PVP; O-2387; β-Keto-prolintane; Prolintanone; Desmethylpyrovalerone |
| Addiction liability | Very high |
| Routes of administration | By mouth, intranasal, inhalation, sublingual, intravenous |
| Drug class | Stimulant; Norepinephrine–dopamine reuptake inhibitor (NDRI) |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 2 hours |
| Duration of action | 3–5 hours |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H21NO |
| Molar mass | 231.339 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (what is this?) (verify) | |
α-Pyrrolidinovalerophenone (α-PVP), also known as α-pyrrolidinopentiophenone , O-2387, β-keto-prolintane, prolintanone,[2][3] or desmethylpyrovalerone, colloquially, it is sometimes called flakka or gravel,[4][5] is a synthetic stimulant of the cathinone class developed in the 1960s that has been sold as a designer drug and often consumed for recreational reasons.[6][7][8] α-PVP is chemically related to pyrovalerone and is the ketone analog of prolintane.[9]
- ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
- ^ "PubChem Substance Record for SID 481087126, alpha-PVP". National Center for Biotechnology Information. May 9, 2023. Retrieved May 7, 2024.
- ^ "PubChem Substance Record for SID 172113243, alpha-Pyrrolidinovalerophenone". National Center for Biotechnology Information. March 3, 2023. Retrieved May 7, 2024.
- ^ Coubrough J (November 2, 2017). "'Zombie drug' flakka may have hit Winnipeg streets: police". CBC News.
- ^ England C, Garcia F (August 17, 2016). "Flakka: What is the 'zombie drug' blamed for face-eating attacks?". The Independent. Archived from the original on 2016-08-18.
- ^ Kolesnikova TO, Khatsko SL, Demin KA, Shevyrin VA, Kalueff AV (January 2019). "DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka")". ACS Chem Neurosci. 10 (1): 168–174. doi:10.1021/acschemneuro.8b00525. PMID 30384587.
- ^ GB 927475, "α-Pyrrolidinovalerophenones", published May 29, 1963
- ^ Logan BK (September 13, 2013). "SOFT Designer Drug Committee Monographs: Alpha-PVP" (PDF). Society of Forensic Toxicologists. Archived from the original (PDF) on April 6, 2015.
- ^ Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH (June 2009). "New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques". Journal of Mass Spectrometry. 44 (6): 952–64. Bibcode:2009JMSp...44..952S. doi:10.1002/jms.1571. PMID 19241365.